Horizon Clinical Research Group.

Cypress, Texas 77429

9 studies enrolling now · 17 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease Psychosis, Asthma, Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Focal Epilepsy, Idiopathic Pulmonary Fibrosis, Lewy Body Dementia Psychosis, Lung Cancer, Moderate to Severe Chronic Obstructive Pulmonary Disease, Parkinson Disease, Parkinson's Disease

Studies at this site

• To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment — Recruiting now
• The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease — Recruiting now
• Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis — Recruiting now
• ACP-204 in Adults With Alzheimer's Disease Psychosis — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma — Recruiting now
• ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study — Enrolling by invitation
• Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis — Enrolling by invitation
• Screening for High Frequency Malignant Disease — Running, not enrolling
• Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Running, not enrolling
• An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED) — Running, not enrolling
• Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
• To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications — Running, not enrolling
• Early Parkinson's Disease Monotherapy With CVN424 — Completed
• A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis — Stopped early